NR4A1 and breast cancer: In addition to this classification, most of Tanzanian patients attending MNH with breast cancer were tested for hormonal receptors (ER and PR), as well as HER-2, followed by a general application of endocrine therapy through Tamoxifen or Trastuzumab at Ocean Road Cancer Institute (ORCI)8,16.